Stock Events

Stock Events

PuraPharm Limited 

HK$0.2700
2
+HK$0.01+1.89% Thursday 03:35

Statistics

Day High
0.27
Day Low
0.27
52W High
0.46
52W Low
0.26
Volume
56,000
Avg. Volume
269,444
Mkt Cap
144.69M
P/E Ratio
159.49
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
Jun 17
HK$0.02
Jun 16
HK$0.09
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

26AugExpected
Q2 2022
Q4 2023
Q2 2024
Q4 2024
Q2 2025
Q4 2025
Q2 2026
-0.1
0.23
0.57
0.9
Expected EPS
N/A
Actual EPS
N/A

Financials

-10.48%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
336.11MRevenue
-35.22MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Beijing Tong Ren Tang Chinese Medicine Company Limited
3613.HK
Mkt Cap10.03B
Jacobson Pharma Corporation Limited specializes in generic drugs and proprietary Chinese medicine, aligning closely with PuraPharm's market.
CSPC Pharmaceutical Group Limited.
1093.HK
Mkt Cap102.27B
CSPC Pharmaceutical Group Limited is a major player in the pharmaceutical industry in China, including traditional Chinese medicine.
3SBIO
1530.HK
Mkt Cap20.36B
3SBio Inc. focuses on biotechnology and pharmaceutical products in China, overlapping with PuraPharm's therapeutic areas.
SSY Group Limited
2005.HK
Mkt Cap12.13B
China Shineway Pharmaceutical Group Limited produces Chinese pharmaceutical products, competing in the same cultural medicine sector.
Luye Pharma Group
2186.HK
Mkt Cap12.14B
Luye Pharma Group Ltd. offers products in several therapeutic areas, including traditional Chinese medicine, competing with PuraPharm.
Weichai Power
2338.HK
Mkt Cap102.67B
Weigao Group Medical Polymer Company Limited manufactures and sells medical products in China, indirectly competing with PuraPharm.
Hansoh Pharmaceutical Group Company Limited
3692.HK
Mkt Cap90.49B
Hansoh Pharmaceutical Group Company Limited, while primarily focused on chemical drugs, also explores traditional Chinese medicine areas.

About

PuraPharm Corporation Limited, an investment holding entity, focuses on the research, development, manufacturing, and global distribution of concentrated Chinese medicine granules (CCMG) and various Chinese healthcare products across Hong Kong, Mainland China, and international markets. Its operations are structured into five key divisions: China CCMG, Hong Kong CCMG, Chinese Healthcare Products, Clinics, and Plantation. The company offers a range of over-the-counter health solutions under brand names such as PuraGold, Haveron, Oncozac, and Immuzac. Beyond product sales, PuraPharm provides a clinic management system for general Chinese medical practices and operates its own chain of Nong's Chinese medicine clinics, which deliver both traditional medical services and CCMG products. The company also oversees the cultivation and trade of raw Chinese herbs, in addition to manufacturing and selling traditional Chinese medicine decoction pieces. Complementing its product offerings, it delivers modernized Chinese medicine services and diagnostic consultations. PuraPharm distributes its goods to hospitals, healthcare institutions, medical professionals, and directly to consumers via an online store. The company currently manages 43 Nong's clinics in Hong Kong and one in Guangxi, China. Founded in 1998, its headquarters are located in Tai Po, Hong Kong.
Show more...
CEO
Yu Ling Chan
Employees
441
Country
Cayman Islands
ISIN
KYG7306Y1044

Listings

HK
HK
1498.HK

0 Comments

Share your thoughts

FAQ

What is PuraPharm Limited stock price today?▼
The current price of 1498.HK is HK$0.27 HKD — it has increased by +1.89% in the past 24 hours. Watch PuraPharm Limited stock price performance more closely on the chart.
What is PuraPharm Limited stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Hong Kong Exchange exchange PuraPharm Limited stocks are traded under the ticker 1498.HK.
Is PuraPharm Limited stock price growing?▼
1498.HK stock has risen by +0% compared to the previous week, the month change is a -3.57% fall, over the last year PuraPharm Limited has showed a -39.33% decrease.
What is PuraPharm Limited market cap?▼
Today PuraPharm Limited has the market capitalization of 144.69M
When is the next PuraPharm Limited earnings date?▼
PuraPharm Limited is going to release the next earnings report on March 31, 2027.
What is PuraPharm Limited revenue for the last year?▼
PuraPharm Limited revenue for the last year amounts to 336.11M HKD.
What is PuraPharm Limited net income for the last year?▼
1498.HK net income for the last year is -35.22M HKD.
Does PuraPharm Limited pay dividends?▼
Yes, 1498.HK dividends are paid annual. The last dividend per share was 0.02 HKD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does PuraPharm Limited have?▼
As of September 05, 2026, the company has 441 employees.
In which sector is PuraPharm Limited located?▼
PuraPharm Limited operates in the Health & Wellness sector.
When did PuraPharm Limited complete a stock split?▼
PuraPharm Limited has not had any recent stock splits.
Where is PuraPharm Limited headquartered?▼
PuraPharm Limited is headquartered in Hong Kong, Cayman Islands.